Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Alveolus
company
About
Alveolus is a leader in the emerging field of non-vascular interventional stenting through next generation stent technology.
- 501 - 1000
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $10M
- Industries
- Medical
- Founded date
- Jan 1, 2001
- Number Of Employee
- 501 - 1000
- Operating Status
- Active
Alveolus is a leader in the emerging field of non-vascular interventional stenting through next generation stent technology.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$10M
Alveolus has raised a total of
$10M
in funding over 2 rounds. Their latest funding was raised on
Jul 30, 2004 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 30, 2004 | Series B | $10M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Alveolus is funded by 2 investors.
EGS Healthcare Capital Partners
and Matignon Technologies
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
EGS Healthcare Capital Partners
|
— | Series B |
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
